Comments
Loading...
ImmuCell (ICCC) Forecast
NewsEarningsImmuCell (ICCC) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestImmuCell (NASDAQ:ICCC) Stock Quotes, Forecast and News Summary
ImmuCell Stock (NASDAQ: ICCC) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy ImmuCell (ICCC) stock?
You can purchase shares of ImmuCell (NASDAQ:ICCC) through any online brokerage.
Who are ImmuCell (ICCC) competitors?
Other companies in ImmuCell’s space includes: Serina Therapeutics (AMEX:SER), Kezar Life Sciences (NASDAQ:KZR), Estrella Immunopharma (NASDAQ:ESLA), Intensity Therapeutics (NASDAQ:INTS) and Barinthus Biotherapeutics (NASDAQ:BRNS).
What is the forecast, or price target, for ImmuCell (ICCC) stock?
There is no analysis for ImmuCell to provide a consensus price target.
What is the current price for ImmuCell (ICCC)?
The stock price for ImmuCell (NASDAQ: ICCC) is $5.15 last updated January 21, 2025 at 9:03 AM EST.
Does ImmuCell (ICCC) pay a dividend?
There are no upcoming dividends for ImmuCell.
When is ImmuCell (NASDAQ:ICCC) reporting earnings?
ImmuCell’s Q4 earnings are confirmed for Tuesday, February 25, 2025.
Is ImmuCell (ICCC) going to split?
There is no upcoming split for ImmuCell.
What sector and industry does ImmuCell (ICCC) operate in?
ImmuCell is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.